Give us a call

(+2) 25075796

Come & visit us

Villa 8, Block 3, Eskan El-Togaryen, Elmokatam, Cairo, Egypt

Email us

info@zi-diligence.com

Request Service

Zi Diligence

The first GCC-accredited center in Egypt.

  • Scientific Excellence, Exceptional Quality & Innovative solutions.
  • Pharmaceutical Research Services.
  • Bioequivalence Studies and Biowaiver Studies.
Discover Services

About Us

Mission and Story About Zi Diligence

Zi Diligence is a leading Pharmaceutical Research Organization established by Dr. Mosaad Morsi in 2014, Egypt, to provide outstanding clinical & bioanalytical services for the pharmaceutical industry in adherence to GCP & GLP principles in accordance with EMEA, FDA, ICH and WHO.

  • Zi Diligence is Approved by Ministry of Health – Egypt, 2015.
  • Approved by Gulf Cooperation Council-GCC, 2017.
  • Certifications; ISO 9001:2015.
  • Accredited by: ISO / IEC 17025:2017.
Dr. Mosaad Morsi

Chairman

More About Us

About Us

Mission and Story About Zi Diligence

Zi Diligence is a leading Pharmaceutical Research Organization established by Dr. Mosaad Morsi in 2014, Egypt, to provide outstanding clinical & bioanalytical services for the pharmaceutical industry in adherence to GCP & GLP principles in accordance with EMEA, FDA, ICH and WHO.

  • Zi Diligence is Approved by Ministry of Health – Egypt, 2015.
  • Approved by Gulf Cooperation Council-GCC, 2017.
  • Certifications; ISO 9001:2015.
  • Accredited by: ISO / IEC 17025:2017.
Dr. Mosaad Morsi

Chairman

More About Us

Zi Diligence Services

Providing expert bioequivalence studies and comprehensive clinical trial services to support pharmaceutical development and regulatory compliance.

Bioequivalence Studies

Zi Diligence has built a brand of excellence in the conduct of bioequivalence and bioaviability studies with more than 250 studies to support generic drug registration.

Read More

Bio-Analysis Services

Laboratory team at Zi Diligence appreciates the importance of delivering quality and innovative solutions to support the drug development programs of our clients.

Read More

Comparative Dissolution Services

Zi Diligence provides comparative dissolution services as biowavier and comparative in-vitro dissolution studies. USP, FDA, and Biopharmaceutics Classification System.

Read More

Pharmacokinetics & statistics

Understanding the basic PK and metabolism characteristics of the drug compound will eventually reveal the appropriate drug regimen for a patient.

Read More

Data Management

Of equal importance is management of data produced by clinical research study. Zi Diligence’s Data Management team is involved right from outset to ensure data correctly.

Read More

Medical Writing

Zi-diligence Medical Writing team provides a full suite of writing services having completed study documents for over 140 studies. This expert team collaborates with all departments.

Read More

Why Zi Diligence

Scientific Excellence, Exceptional Quality & Innovative solutions

Quality

From protocol development through regulatory submission, quality is assured – every step of the way.

Responsive

Our dedicated Project Managers work closely with you to ensure all aspects of your study are well managed with fully transparent communication.

Nimble

Working with Zi-diligence means you have a partner that is agile enough to pivot and make adjustments when needed.

On-Time Results

Niche experts including PK, Data Management and Medical Writing deliver the results you need on time.

Zi Diligence Achievements

We have made a large number of contributions to global human health over the past 8 years

+ 0
Validated Methods
+ 0
Regulatory Inspections
+ 0
Studies
+ 0
Samples Analyzed
+ 0
Experts
+ 0
Countries

Zi Diligence Clients

We are trusted by hundreds of multinational, international, and national clients

client-int-10
client-int-11
client-int-12
client-int-13
client-25
client-58
client-59
client-int-1
client-int-2
client-int-3
client-int-4
client-int-5
client-int-6
client-int-7
client-int-8
client-int-9
client-26
client-27
client-28
client-29
client-30
client-31
client-32
client-33
client-34
client-35
client-36
client-37
client-38
client-39
client-40
client-41
client-42
client-43
client-44
client-45
client-46
client-47
client-48
client-49
client-50
client-51
client-52
client-53
client-54
client-55
client-56
client-57
client-60
client-61
client-1
client-2
client-3
client-4
client-5
client-6
client-7
client-8
client-9
client-10
client-11
client-12
client-13
client-14
client-15
client-16
client-17
client-18
client-19
client-20
client-21
client-22
client-23
client-24
ain
university-1
university-2
university-3
university-4

Scientific Publications

Collection of Pharmaceutical Science Publications

44054654
A novel LC-MS/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma
222065464
Development and validation of liquid chromatography-electrospray-tandem mass spectrometry method for determination of flibanserin in human plasma
115464780
Development a validated highly sensitive LC-MS/MS method for simultaneous quantification of Ledipasvir, sofosbuvir and its major metabolite GS-331007 in human plasma
000654655
Development and validation of LC-MS/MS method for simultaneous determination of sofosbuvir and daclatasvir in human Plasma
35465165486
Pharmacokinetic evaluation of daclatasvir and ledipasvir in healthy volunteers using a validated highly sensitive spectrofluorimetric method

SERVICE REQUEST

We’d like to hear from you. If you have any questions or comments, please fill out the brief form below, and one of our friendly representatives will be in touch.